US News & World Report features a story on Sanaria's new finding that our experimental vaccine against malaria has provided protection for some against the illness for more than a year.
Some people will go to extreme lengths to avoid mosquito bites. They'll wear long sleeves and pants in the heat of summer, surround themselves with citronella candles and torches, and spray foul-smelling chemicals all over their bodies—or simply not set foot outside when they know the bugs are biting. Stephen Hoffman isn't quite like those people.
Sanaria is a Maryland-based biotechnology company developing innovative vaccines that protect against malaria. We are focused on African children, the population most urgently in need of protection.